Imatinib‐induced psoriasiform eruption in a patient with chronic myeloid leukemia

E-ISSN： 1096-8652|93|3|467-468

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.93, Iss.3, 2018-03, pp. : 467-468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant

Acta Haematologica, Vol. 120, Iss. 3, 2008-11 ,pp. : 146-149

Karger

Access to resources Recommend Favorite

Hematologic Relapse after 2 Years on a Non-Authorized Copy Version of Imatinib in a Patient with Chronic Myeloid Leukemia in Chronic Phase: A Case Report

Case Reports in Oncology, Vol. 3, Iss. 2, 2010-07 ,pp. : 272-276

Karger

Access to resources Recommend Favorite

Imatinib cessation in children and adolescents with chronic myeloid leukemia in chronic phase

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 2, 2014-02 ,pp. : 355-357

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of Imatinib in Chronic Myeloid Leukemia in Blastic Crisis Presenting as Cholestatic Jaundice

Acta Haematologica, Vol. 118, Iss. 3, 2007-09 ,pp. : 141-145

Karger

Access to resources Recommend Favorite

More about Imatinib and Nilotinib Combination Therapy in Chronic Myeloid Leukemia

Acta Haematologica, Vol. 129, Iss. 1, 2012-09 ,pp. : 18-19

Karger

Access to resources Recommend Favorite